Iti Pharma And Healthcare Fund Overview | ||||||
---|---|---|---|---|---|---|
Category | Sectoral/ Thematic | |||||
BMSMONEY | Rank | 3 | ||||
Rating | ||||||
Growth Option 21-02-2025 | ||||||
NAV | ₹15.08(R) | -1.36% | ₹16.13(D) | -1.35% | ||
Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
Lumpsum | Regular | 9.8% | 17.77% | -% | -% | -% |
Direct | 11.89% | 20.19% | -% | -% | -% | |
Nifty 500 TRI | 3.79% | 13.47% | 16.97% | 13.57% | 12.47% | |
SIP (XIRR) | Regular | 0.44% | 21.15% | -% | -% | -% |
Direct | 2.42% | 23.58% | -% | -% | -% | |
Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
0.63 | 0.32 | 0.79 | 5.47% | 0.12 | ||
Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
15.83% | -23.02% | -12.0% | 0.86 | 11.35% |
NAV Date: 21-02-2025
Scheme Name | NAV | Rupee Change | Percent Change |
---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option | 15.08 |
-0.2100
|
-1.3600%
|
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 15.08 |
-0.2100
|
-1.3600%
|
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | 16.13 |
-0.2200
|
-1.3500%
|
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option | 16.13 |
-0.2200
|
-1.3500%
|
Review Date: 21-02-2025
ITI Pharma and Healthcare Fund has exhibited very good performance in the Sectoral/ Thematic Fund category. The fund has rank of 3 out of 20 funds in the category. The fund has delivered return of 9.8% in 1 year and 17.77% in 3 years. The category average for the same periods is 4.9% and 14.59% respectively, which shows very good return performance of fund in the category. The fund has exhibited standard deviation of 15.83, VaR of -23.02, Average Drawdown of -6.89, Semi Deviation of 11.35 and Max Drawdown of -12.0. The category average for the same parameters is 14.44, -18.97, -6.36, 10.19 and -13.2 respectively. The fund has average risk in the category.KPIs* | Fund | Nifty 500 TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | -7.34 | -3.35 |
-5.23
|
-15.08 | -0.83 | 24 | 29 | Average |
3M Return % | -8.60 | -5.00 |
-6.80
|
-17.77 | -1.41 | 21 | 30 | Average |
6M Return % | -6.60 | -11.16 |
-12.27
|
-25.15 | -4.83 | 5 | 30 | Very Good |
1Y Return % | 9.80 | 3.79 |
4.90
|
-3.85 | 13.40 | 6 | 26 | Very Good |
3Y Return % | 17.77 | 13.47 |
14.59
|
8.65 | 24.95 | 5 | 20 | Very Good |
1Y SIP Return % | 0.44 |
-11.10
|
-32.25 | 0.78 | 2 | 26 | Very Good | |
3Y SIP Return % | 21.15 |
14.90
|
8.68 | 27.80 | 3 | 20 | Very Good | |
Standard Deviation | 15.83 |
14.44
|
11.55 | 18.43 | 15 | 20 | Average | |
Semi Deviation | 11.35 |
10.19
|
8.23 | 13.82 | 17 | 20 | Poor | |
Max Drawdown % | -12.00 |
-13.20
|
-22.23 | -7.90 | 8 | 20 | Good | |
VaR 1 Y % | -23.02 |
-18.97
|
-30.37 | -13.22 | 17 | 20 | Poor | |
Average Drawdown % | -6.89 |
-6.36
|
-9.44 | -4.18 | 12 | 20 | Average | |
Sharpe Ratio | 0.63 |
0.51
|
0.08 | 1.17 | 6 | 20 | Good | |
Sterling Ratio | 0.79 |
0.65
|
0.27 | 1.24 | 5 | 20 | Very Good | |
Sortino Ratio | 0.32 |
0.28
|
0.07 | 0.62 | 6 | 20 | Good | |
Jensen Alpha % | 5.47 |
1.56
|
-6.67 | 11.91 | 5 | 20 | Very Good | |
Treynor Ratio | 0.12 |
0.08
|
0.01 | 0.18 | 5 | 20 | Very Good | |
Modigliani Square Measure % | 15.49 |
14.37
|
6.71 | 24.99 | 6 | 20 | Good | |
Alpha % | 3.69 |
0.86
|
-5.50 | 11.81 | 6 | 20 | Good |
KPIs* | Fund | Nifty 500 TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | -7.19 | -3.35 | -5.12 | -15.00 | -0.71 | 24 | 29 | |
3M Return % | -8.16 | -5.00 | -6.52 | -17.40 | -1.03 | 21 | 30 | |
6M Return % | -5.72 | -11.16 | -11.74 | -24.46 | -4.28 | 4 | 30 | |
1Y Return % | 11.89 | 3.79 | 6.12 | -2.91 | 14.40 | 4 | 26 | |
3Y Return % | 20.19 | 13.47 | 15.89 | 9.24 | 26.19 | 3 | 20 | |
1Y SIP Return % | 2.42 | -10.02 | -31.54 | 2.42 | 1 | 26 | ||
3Y SIP Return % | 23.58 | 16.23 | 10.09 | 29.28 | 3 | 20 | ||
Standard Deviation | 15.83 | 14.44 | 11.55 | 18.43 | 15 | 20 | ||
Semi Deviation | 11.35 | 10.19 | 8.23 | 13.82 | 17 | 20 | ||
Max Drawdown % | -12.00 | -13.20 | -22.23 | -7.90 | 8 | 20 | ||
VaR 1 Y % | -23.02 | -18.97 | -30.37 | -13.22 | 17 | 20 | ||
Average Drawdown % | -6.89 | -6.36 | -9.44 | -4.18 | 12 | 20 | ||
Sharpe Ratio | 0.63 | 0.51 | 0.08 | 1.17 | 6 | 20 | ||
Sterling Ratio | 0.79 | 0.65 | 0.27 | 1.24 | 5 | 20 | ||
Sortino Ratio | 0.32 | 0.28 | 0.07 | 0.62 | 6 | 20 | ||
Jensen Alpha % | 5.47 | 1.56 | -6.67 | 11.91 | 5 | 20 | ||
Treynor Ratio | 0.12 | 0.08 | 0.01 | 0.18 | 5 | 20 | ||
Modigliani Square Measure % | 15.49 | 14.37 | 6.71 | 24.99 | 6 | 20 | ||
Alpha % | 3.69 | 0.86 | -5.50 | 11.81 | 6 | 20 |
Investment Period | Regular | Direct | ||
---|---|---|---|---|
Return % | Current Value of ₹ 10000 | Return % | Current Value of ₹ 10000 | |
1D | -1.36 | ₹ 9,864.00 | -1.35 | ₹ 9,865.00 |
1W | 0.06 | ₹ 10,006.00 | 0.10 | ₹ 10,010.00 |
1M | -7.34 | ₹ 9,266.00 | -7.19 | ₹ 9,281.00 |
3M | -8.60 | ₹ 9,140.00 | -8.16 | ₹ 9,184.00 |
6M | -6.60 | ₹ 9,340.00 | -5.72 | ₹ 9,428.00 |
1Y | 9.80 | ₹ 10,980.00 | 11.89 | ₹ 11,189.00 |
3Y | 17.77 | ₹ 16,336.00 | 20.19 | ₹ 17,363.00 |
5Y | ₹ | ₹ | ||
7Y | ₹ | ₹ | ||
10Y | ₹ | ₹ | ||
15Y | ₹ | ₹ |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
Investment Period | Invested Amount | Regular | Direct | ||
---|---|---|---|---|---|
XIRR % | Current Value of Invested Amount | XIRR % | Current Value of Invested Amount | ||
1Y | ₹ 12000 | 0.44 | ₹ 12,028.72 | 2.42 | ₹ 12,157.45 |
3Y | ₹ 36000 | 21.15 | ₹ 49,102.60 | 23.58 | ₹ 50,784.55 |
5Y | ₹ 60000 | ₹ | ₹ | ||
7Y | ₹ 84000 | ₹ | ₹ | ||
10Y | ₹ 120000 | ₹ | ₹ | ||
15Y | ₹ 180000 | ₹ | ₹ |
Date | Iti Pharma And Healthcare Fund NAV Regular Growth | Iti Pharma And Healthcare Fund NAV Direct Growth |
---|---|---|
21-02-2025 | 15.081 | 16.1345 |
20-02-2025 | 15.2884 | 16.3556 |
19-02-2025 | 15.1605 | 16.218 |
18-02-2025 | 15.1127 | 16.166 |
17-02-2025 | 15.1999 | 16.2584 |
14-02-2025 | 15.072 | 16.1191 |
13-02-2025 | 15.5085 | 16.585 |
12-02-2025 | 15.4165 | 16.4859 |
11-02-2025 | 15.5032 | 16.5777 |
10-02-2025 | 15.9618 | 17.0672 |
07-02-2025 | 16.3323 | 17.4607 |
06-02-2025 | 16.3697 | 17.4997 |
05-02-2025 | 16.3236 | 17.4496 |
04-02-2025 | 16.1834 | 17.2988 |
03-02-2025 | 15.923 | 17.0196 |
31-01-2025 | 15.8617 | 16.9514 |
30-01-2025 | 15.8239 | 16.9102 |
29-01-2025 | 15.671 | 16.7459 |
28-01-2025 | 15.3386 | 16.3899 |
27-01-2025 | 15.7227 | 16.7994 |
24-01-2025 | 16.1948 | 17.3012 |
23-01-2025 | 16.5253 | 17.6533 |
22-01-2025 | 16.284 | 17.3947 |
21-01-2025 | 16.2758 | 17.3851 |
Fund Launch Date: 17/Nov/2021 |
Fund Category: Sectoral/ Thematic |
Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved. |
Fund Description: An open ended equity scheme investing in Pharma and Healthcare |
Fund Benchmark: Nifty Healthcare Total Return Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.